Aussie Sale Of iCeutica To Iroko Of U.S. Called Signal To Biotechs
This article was originally published in PharmAsia News
Executive Summary
Australia's iCeutica has agreed to be acquired by U.S. drug maker Iroko Pharmaceuticals, reportedly for $63.5 million, according to the chairman of both private companies